KEC International's Q1 FY27 (quarter ended 30 June 2026) results contain the clearest confirmation anywhere in this report of the "commodity EPC execution, margin under structural pressure" story: consolidated EBITDA margin fell to 5.8%, down from 7.0% a year earlier, with standalone margin closer to 4% — this despite an order book that had just crossed a record ~₹40,000 crore. Consolidated revenue was flat YoY at ₹5,024 crore, and PAT fell ~42% YoY to ₹73 crore. Management's own guidance does not promise a quick fix: double-digit margins are not expected before FY28, with only "high-single-digit" margins targeted for that year — this report takes that guidance at face value rather than assuming an earlier recovery.
KEC is the RPG Group's flagship infrastructure EPC company, built on power transmission-line and substation EPC, tower/conductor/cable manufacturing (~4.7 lakh MT/year combined capacity), civil construction, railway electrification and solar EPC, with roughly 37% of business coming from international markets. Two structural, not cyclical, risks sit underneath the current margin print. First, roughly 40-50% of the order book is fixed-price and directly exposed to steel-price volatility (aluminium and zinc are hedged; steel is not). Second, working capital is deteriorating — CRISIL estimates gross current assets at 320-330 days, driven by slow collections from water, railway and certain overseas (including Afghanistan receivable) exposures. Credit ratings are mixed and weaker than most peers in this report: CARE reaffirmed KEC at A+/Stable in December 2025 (itself a reaffirmation of a September 2024 downgrade, not a fresh upgrade), while ICRA rates the company AA- with a Stable outlook (only recently moved off Negative, ~25 November 2025) — a genuine, unresolved cross-agency discrepancy this report states rather than picks a side on. Either reading sits a full notch or more below Thermax (covered separately in this report), whose ratings sit at AA+/Stable with both agencies.
The stock is cheap — ~17.9x trailing P/E, having fallen roughly 52.8% over the trailing year — but this report reads that cheapness as a value-trap risk, not a value opportunity: the market is pricing in exactly the structural margin and working-capital problems management itself has now confirmed and guided against. KEC does have a data-centre angle: a July 2026 order batch worth ₹1,180 crore included the company's first-ever transmission-line project built specifically to power a data centre (a 400 kV line in Western India), distinct from a separate, pre-existing civil-construction DC business (five projects, ~100 MW, naming Yotta, Digital Edge and Nxtra as clients). Both are genuine, but both are new and small next to a ~₹40,000 crore order book and a business whose blended margins have just fallen through 6%.
Net: a SELL. KEC's order-book growth is real, its DC-linked order wins are real, and its board independence and rating trajectory (ICRA's outlook stabilisation) show some genuine positives — but none of that changes a business whose core margin economics moved the wrong way in the most recent quarter management itself does not expect to normalise for at least six more quarters. This report is unwilling to call a stock down more than half over a year, on management's own weak forward guidance, a value opportunity simply because it is statistically cheap.
KEC is a mainboard NSE/BSE-listed company subject to the full SEBI LODR regime. Chairman (Harsh Goenka) and Managing Director/CEO (Vimal Kejriwal) roles are held by separate individuals, so the heightened (≥50%) independent-director threshold that applies to executive-chaired boards is not triggered by that rule. Seven named independent directors sit on the board, a composition this research assesses as consistent with SEBI LODR's baseline requirements, though the exact current total board size was not independently re-confirmed from a primary filing in this pass.
Chairman and MD/CEO roles are separated — Goenka chairs the RPG Group and several of its operating companies concurrently (a standard conglomerate governance pattern), while Kejriwal has run KEC as MD/CEO since April 2015 and was most recently reappointed for a further term effective 1 April 2025. The independent-director slate (Vimal Bhandari, M.S. Unnikrishnan, Arvind Singh, Harsh Vardhan Shringla, Neera Saggi, Dr. Shirish Sankhe, Vikram Gandhi) is substantial and diversified, including a former Foreign Secretary — a genuinely relevant appointment given KEC's international revenue exposure and the geopolitical risks (e.g., Afghanistan receivables, West Asia disruption) documented elsewhere in this section. No SEBI enforcement action or insider-trading finding was found against the company.
Kejriwal was listed as "retiring by rotation and offering himself for re-appointment" at the 21 August 2026 AGM; this research could not confirm the outcome of that vote. The cross-agency rating discrepancy (CARE A+ vs. ICRA AA-) is itself a governance-adjacent disclosure question this report could not resolve — investors relying on a single agency's rating would reach different conclusions about the same company. CRISIL's current long-term (bank-facility) rating for KEC could not be located, with only a short-term commercial-paper rating confirmed.
None confirmed as adjudicated matters. No SEBI enforcement action or insider-trading finding was found. This research could not verify the current statutory auditor's name, CFO identity, or any pending litigation/related-party-transaction disclosures for KEC — an absence of evidence, not affirmative clearance, and a real gap for a company of this scale and international exposure.
Confirmation of the 21 August 2026 AGM's vote on Kejriwal's re-appointment; reconciliation (or at least continued monitoring) of the CARE-vs-ICRA rating gap; confirmation of CRISIL's current long-term bank-facility rating; and disclosure of the statutory auditor, CFO and any pending litigation from the FY26 annual report.
Structurally reasonable but incompletely disclosed. Separated Chairman/MD roles and a genuinely diversified independent-director slate are real positives, and nothing found in this research points to misconduct. But an unresolved cross-agency credit-rating discrepancy, an unconfirmed CRISIL long-term rating, and several unverified disclosure items (auditor, CFO, litigation) leave real gaps — none of which drives this report's SELL call, which rests on the operating-margin and working-capital evidence in the Summary above, not on governance concerns.
CMP of ₹404 (18 September 2026) divided by the disclosed trailing P/E of 17.9x (screener.in) implies trailing EPS of roughly ₹22.6 — broadly consistent with FY26 consolidated PAT of ₹606 crore over an implied ~26.6 crore shares (market cap ÷ CMP), which independently works out to ~₹22.8; this report uses the P/E-implied ₹22.6 as its EPS anchor since it is directly sourced rather than back-derived. Given management's own guidance that double-digit margins will not return before FY28 and that Q1 FY27 PAT was already down ~42% YoY, we assume next-twelve-months EPS stays broadly flat (~₹22.5) rather than growing with the guided 12-15% revenue expansion — the margin drag more than offsets top-line growth in this report's base case. We apply a target multiple band at or below the current 17.9x trailing multiple, reflecting continued structural margin and working-capital risk rather than a re-rating:
| Scenario | Target P/E (FY27E) | FY27E EPS (~) | Target price | Upside/(downside) |
|---|---|---|---|---|
| Bear | 13.0x | 22.5 | 293 | (27.5)% |
| Base | 15.5x | 22.5 | 349 | (13.6)% |
| Bull | 18.5x | 22.5 | 416 | +3.0% |
Base case rounded to ₹349. Even our bull-case scenario, applying a target multiple modestly above the current trailing 17.9x, produces only marginal upside from the current price — a sign of how little room this report finds for the stock to work even on a constructive multiple assumption while the margin story remains unresolved. Named brokerage targets found in this research sit well above this report's own range — JM Financial (Buy, ₹580) and ICICI Securities (Buy, ₹550) — alongside a 24-analyst consensus average of ₹582.79 (range ₹411-736); a separate, larger aggregator's claimed consensus of ₹961 is flagged in the underlying research as very likely a stale, pre-decline figure that has not been refreshed for the ~53% one-year share-price fall, and this report explicitly does not use it. This report's own, more conservative base case reflects its weighting of the Q1 FY27 margin collapse and management's FY28 guidance, both dated after most cited brokerage targets.
Upgrade triggers: consolidated EBITDA margin recovering toward high-single-digits ahead of management's own FY28 timeline; a resolved, converged credit rating from CARE and ICRA at the higher end of the current range; working capital improving materially below the current 320-330-day level; or a meaningfully larger, repeat-order-confirmed data-centre T&D pipeline. Downgrade triggers: a further margin miss versus the FY28 double-digit guidance itself; a formal downgrade from either CARE or ICRA; further deterioration in working capital or a further increase in net debt; or fresh evidence that the fixed-price order-book share is rising rather than falling.
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 19,914 | 21,847 | 23,506 |
| EBITDA margin | 7% (6.82%) | 8% (7.70%) | 8% |
| Net profit (PAT) | 347 | 571 | 606 |
| Selected metrics | Value |
|---|---|
| ROE / ROCE | 11.4% / 16.5% |
| Order book, incl. L1 (mid-2026) | ~₹40,000 cr |
| Q1 FY27 EBITDA margin (YoY) | 5.8% (from 7.0%) |
| Q1 FY27 PAT (YoY) | ₹73 cr ((42)%) |
| Gross current assets (working capital) | 320-330 days |
Source: screener.in (18 Sep 2026 fetch, consolidated basis), cross-checked against CARE Ratings (16 Dec 2025) and CRISIL (7 May 2026) rationales. FY26 "Operating PAT" of ₹650 crore was cited in one results-coverage source, versus screener's ₹606 crore net-profit figure shown above — this report could not fully reconcile which figure excludes exceptional items, and flags rather than resolves the gap. CARE's more precise EBITDA-margin figures (6.82% FY24 → 7.70% FY25) are shown in parentheses alongside screener's rounded 7%/8% bands.
Dart Consultants is a market intelligence and technology service provider, not a SEBI-registered Investment Adviser or Research Analyst. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The SELL rating above is an educational device for summarising public information, not a regulated recommendation. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, KEC International Limited, and have received no compensation from the company.
| 12-month target | ₹349 |
| CMP (18 Sep 2026) | ₹404 |
| Implied upside | (13.6)% |
| Rating | SELL |
| Market cap | ₹10,761 cr |
| P/E (trailing) | ~17.9x |
| Book value/share | ₹231 |
| 52-week range | ₹938 / ~₹390-400 |
| Credit rating | CARE A+/Stable; ICRA AA-/Stable |
| Promoters (RPG Group) | 50.10% |
| DII | 23.34% |
| FII | 9.92% |
| Public | 16.64% |
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 19,914 | 21,847 | 23,506 |
| EBITDA margin | 7% | 8% | 8% |
| PAT | 347 | 571 | 606 |